Sotac Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Sotac Pharmaceuticals has a total shareholder equity of ₹509.4M and total debt of ₹279.9M, which brings its debt-to-equity ratio to 54.9%. Its total assets and total liabilities are ₹1.2B and ₹645.8M respectively. Sotac Pharmaceuticals's EBIT is ₹55.2M making its interest coverage ratio 3.7. It has cash and short-term investments of ₹5.2M.
Key information
54.9%
Debt to equity ratio
₹279.88m
Debt
| Interest coverage ratio | 3.7x |
| Cash | ₹5.21m |
| Equity | ₹509.35m |
| Total liabilities | ₹645.75m |
| Total assets | ₹1.16b |
Recent financial health updates
Recent updates
Here's Why We Think Sotac Pharmaceuticals (NSE:SOTAC) Is Well Worth Watching
Sep 28
We Think Sotac Pharmaceuticals (NSE:SOTAC) Is Taking Some Risk With Its Debt
Jul 24Sotac Pharmaceuticals Limited's (NSE:SOTAC) 31% Price Boost Is Out Of Tune With Earnings
Jun 28Sotac Pharmaceuticals Limited (NSE:SOTAC) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Feb 29Financial Position Analysis
Short Term Liabilities: SOTAC's short term assets (₹595.2M) exceed its short term liabilities (₹530.0M).
Long Term Liabilities: SOTAC's short term assets (₹595.2M) exceed its long term liabilities (₹115.8M).
Debt to Equity History and Analysis
Debt Level: SOTAC's net debt to equity ratio (53.9%) is considered high.
Reducing Debt: Insufficient data to determine if SOTAC's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: SOTAC's debt is well covered by operating cash flow (30.6%).
Interest Coverage: SOTAC's interest payments on its debt are well covered by EBIT (3.7x coverage).